Subject: Immune Response Shares Plunge
Date: Published: 6/10/93 (17 lines)
Source: Wall Street Journal. Copyright Dow Jones & Co. Inc.

    What's News --
    Business and Finance

[28 lines irrelevant to AIDS omitted.  --sysop]

    Immune Response shares plunged $5.625, or 26%, to $16, after
 investors reacted skeptically to its update on a drug that is
 supposed to boost the immune systems of AIDS patients.

[This article is made available here by Dow Jones Co. for the
 personal and non-commercial use of callers to this bbs, in the
 hope that it will be of some help to those who are suffering
 from the disease and others who are seeking to help them.]